GB590 Corporate Social Responsibility Prof. Ray Kalinski By Willette Marchany Rivera December 13, 2010.

Slides:



Advertisements
Similar presentations
Pricing and paying for medicines Ad Antonisse AstraZeneca BV April 2005.
Advertisements

Atlas Copco Group Q4 Results February 2, Q4 - highlights  Order growth continued  Record operating profit –All business areas above 20% operating.
Janssen is proud to feature artwork created by people affected by the illnesses and diseases we are committed to treating and preventing. Key Sustainability.
History and Geography: The Foundations of Culture
The International Trade Administration: Clean Energy Priorities and Programs Mary Saunders Assistant Secretary of Commerce for Manufacturing and Services.
Past, Present, Future December 6, 2004 Past, Present, Future December 6, 2004 Physicians, Hospitals and the Evolution of Electronic Medical Records (EMR)
Monroe L. Weber-Shirk S chool of Civil and Environmental Engineering Global Resources 
ECON 850 Health Economics Gilleskie Lecture 1: Introduction What is economics? What is health economics?
Technology and Health Care HCA 701 November 10, 2005.
Center for Sustainable Tourism East Carolina University Business Research Division Leeds School of Business University of Colorado at Boulder National.
Drug Pricing in Canada Victoria Brown, Anureet Sohi, Lisa Weger SPHA 511.
Federal Energy and Environmental Regulation Agencies and Laws
The World Of International Business
Next >>.
Part 1 Business in a Changing World © 2015 McGraw-Hill Education.
4 Chapter Business Ethics and Social Responsibility pp
History and Geography: The Foundations of Culture Chapter 3 McGraw-Hill/Irwin© 2005 The McGraw-Hill Companies, Inc. All rights reserved. PowerPoint presentation.
Mike Murray Chair of EFPIA EH&S AHG MPA Conference Uppsala
International Textile Ltd. 1 5 October September 2012 Corporate Social & Environmental Responsibility 1.
The concept of Managing Sustainability on Toyota
INTRODUCTION TO RA.
Sustainability Issues
Business Ethics and Social Responsibility
Climate Change Uncertainties: Opportunities for Business Innovation? The Business Perspective: UPMC Allison Robinson, PhD, MS Director, Environmental Initiatives.
Introduction to Drug Rediscovery John Lisman Attorney-at-law Lisman Legal Life sciences Insert your logo in this area then delete this text box.
BA 101 Introduction to Business 2. Ethics and Social Responsibility.
© Prentice Hall, 2005Business In Action 3eChapter Practicing Ethical Behavior and Social Responsibility.
© The McGraw-Hill Companies, Inc., 2002 All Rights Reserved. McGraw-Hill/ Irwin 20-1 Business and Society POST, LAWRENCE, WEBER Global Social Issues for.
Strictly confidential How to achieve sustainability in rapidly changing environment? Pavle Marjanović, Country Manager for Actavis Republic of Serbia and.
Tyler S Teacher Malone Introduction to Business Chapter 4 Vocabulary This is prepared for the Business student by a student in your business.
MarketsandMarkets Presents Biocides Market would be worth $9.6 Billion by 2018 growing at a CAGR of 4.6% from 2013 to 2018.
Factors Influencing the Automobile Industry. Factors that affect Automobile Industry  Anti pollution issues  Alternatives cars such as electric cars.
McGraw-Hill/Irwin Strategic Management, 10/e Copyright © 2007 The McGraw-Hill Companies, Inc. All rights reserved. Corporate Social Responsibility and.
 Overview of pharma industry  Know associate industry in pharma  Environmental forces  Stakeholders.
CH 23: ECONOMICS, ENVIRONMENT, AND SUSTAINABILITY Andrew, Summer, Nisha.
Regulatory/Requirements Review Process Fall, 2000 Survey In this day of economic and trade globalization, multinational companies are responsible for an.
Sophia Tickell MeTA IAG Chair Pharma Futures 3, the external environment, MeTA’s private sector plans MeTA29/01/20161.
Business Ethics and Social Responsibility Chapter 4 Introduction to Business.
Sustainability in the Supply Chain 5 © 2014 Pearson Education, Inc. SUPPLEMENT.
CARDINAL HEALTH, Inc. GLOBAL OPERATIONS By Cornel Daniel Gherman GB 540:02 Economics for Global Decision Makers Dr.: Barbara-Leigh Tonelli October 10 th,
Section 6.1 Government and Laws Chapter 6 legal and ethical issues Section 6.2 Social Responsibilities and Ethics.
Social Responsibility and Ethics Chapter 6 Section 2.
Chapter 2 Organizations: Their Political, Structural and Economic Environment By: Arnica Trazo.
GB 590 Corporate Social Responsibility Dr. Mary Dereshiwsky John McGonegal March 26, 2012.
MarketsandMarkets Presents Global Water Treatment Chemicals Market in Soft Drinks By Type, Region and Process (2010 – 2015)
Regulatory System of Research on New Infectious Diseases the Thai Perspective Soraj Hongladarom, Center for Ethics of Science and Technology Chulalongkorn.
Anti-Corrosion Coating Market Opportunities and Forecasts,
Renewable Energy in Tourism Initiative (RETI)
Company Selection: Integrating sustainability criteria
Government’s Role in the U.S. Economy
MarketsandMarkets Presents Gas Chromatography Market by Instrument, Application & End user - Global Forecast to html.
MarketsandMarkets Presents Gas Chromatography Market Forecast 2022 : Increasing Focus on Waste Water Treatment html.
MarketsandMarkets Presents Gas Chromatography Market, By Accessories & Consumables (2017 vs. 2022) html.
MarketsandMarkets Presents Gas Chromatography Market: Scope, Stakeholders & Global Forecast html.
MarketsandMarkets Presents Gas Chromatography Market Size by Products and Application with Sales, Revenue, CAGR and Forecasts html.
MarketsandMarkets Presents Gas Chromatography Market is expected to reach $3.67 Billion by 2022 from $2.64 Billion in
Green Logistics.
LT: Explain the roles government plays in our free enterprise system
The importance of dialogue between regulators
LT: Explain the roles government plays in our free enterprise system
Identify the roles government plays in our free enterprise system
Identify the roles government plays in our free enterprise system
List and Identify the different types of businesses
Bioethics and Responsible Leadership
Government’s Role in the U.S. Economy
4 Chapter Business Ethics and Social Responsibility pp
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET 2017 – 2025 Published by :Accurize Market Research Pvt. Ltd. Copyright © 2019 Accurize Market Research.
SWOT and PESTEL Analysis By MyAssignmenthelp.com MyAssignmenthelp.com.
Presentation transcript:

GB590 Corporate Social Responsibility Prof. Ray Kalinski By Willette Marchany Rivera December 13, 2010

 Introduction: Industry Overview  Objectives  Industry Audit ◦ Social ◦ Environmental ◦ Economic  Industry Stakeholders Analysis ◦ Stockholders ◦ Consumers ◦ Employees  Conclusion  References

 Ethical drugs for human consumption at ex-factory prices: ◦ Research ◦ Development ◦ Manufacture ◦ Marketing  5.3% industry market value growth in 2009 translates to $1,071.7 billion  Expected market value increase of 30.9% from 2009 to 2014  Pharmaceuticals is the largest segment: 75.7% of the industry's total value.  Americas accounts for 50.5% of the industry value

 Track important development of social, environmental, and economic issues affecting the pharmaceutical industry  Explore the positions and perspectives of the various stakeholders with regards to the social, environmental, and economic matters affecting the industry

 Use of natural/alternative medicine and “green” trends  Safety concerns about drugs and their secondary effects  Poor countries where the indigent can’t pay to acquire medicines  Treating symptoms instead of finding a cure for the disease or condition  Marketing methods and direct to consumer advertising. Industry Audit

 Strict environmental laws in United States and Europe  Fuel consumption and air pollution  Climate change ◦ Volatile Organic Compounds (VOC) ◦ Ozone Depleting Compounds (ODC)  Water usage, consumption and treatment  Energy efficiency  Waste and efficient packaging Industry Audit

 Research & development costs  High price of pharmaceutical drugs  International trade: Safety regulations vary between countries pose barriers to entry  Tax increases and changes in fiscal exemptions  Freight costs: Fuel prices and Transportation Security Agency regulations Industry Audit

 Profits  Drug patents  Ethical behavior SuppliersSocietyEnvironment Employees Medical Professionals Patients Stockholders &. Investors Industry Stakeholders

 Consumer’s rights ◦ Receive accurate information  Human rights ◦ The right to health SuppliersSocietyEnvironment Employees Medical Professionals Patients Stockholders &. Investors Industry Stakeholders

 Physicians & Pharmaceutical Medicine  Rewarding ethical behavior  Best companies to work for SuppliersSocietyEnvironment Employees Medical Professionals Patients Stockholders &. Investors Industry Stakeholders

 Pharmaceutical industry is strong and profitable  Several ethical concerns regarding drug safety, efficiency and sustainability

Alternative Medicine Industry Overview. (2009, April 27). Themedica: Global Health Marketplace. Retrieved December 13, 2010 from Kitsis, E. A. (2009). Rx for the Pharmaceutical Industry: Call Your Doctors. Hastings Center Report, 39(4), Retrieved from EBSCOhost. Lawrence, A. T. (2011). Merck, the FDA, and the Vioxx recall. In Lawrence, A. T. Weber, J., Business and Society: Stakeholders, Ethics, Public Policy (pp ). New York: McGraw-Hill. Luthra, R. (2006, November). Health-care patents and interests of patients. Bulletin of the World Health Organization, 84 (11). (pp.919) Springfield, MA: Woman’s Health Education Center Melia, M. (2007, November 26). Plantas farmacéuticas abandonan Puerto Rico. La Voz. Retrieved December 13, 2010 from Muhairwe, A. (2008). Harmonization of drug regulation in East Africa: the way forward. Presentations from 13th International Conference of Drug Regulatory Authorities (ICDRA). World Health Organization. Retrieved December 13,2010 from _legislation/icdra/2_Uganda_HarmonisationDrugRegulation-EastAfrica.pdf Pharmaceuticals, Biotechnology & Life Sciences Industry Profile: Global. (2010). Pharmaceuticals, Biotechnology & Life Sciences Industry Profile: Global, 1. Retrieved from EBSCOhost. Slowik, E. (2010). Newton: Big pharma seeks partners, not purchases. Grand Rapids Business Journal, 28(41), 3. Retrieved from EBSCOhost. The right to the highest attainable standard of health: General Comment No. 14. (2000). United Nations Economic and Social Council. Retrieved December 12, 2010 from